Navigation Links
WellPoint Announces Appearance at Upcoming Conference
Date:1/7/2009

INDIANAPOLIS, Jan. 7 /PRNewswire/ -- WellPoint, Inc. (NYSE: WLP) announced today that senior management is scheduled to present at the 27th Annual J.P. Morgan Healthcare Conference on Jan. 12, 2009, at 9:30 a.m. Pacific Standard Time (12:30 p.m. Eastern Standard Time).

WellPoint, Inc. is scheduled to release earnings results for the three months ended Dec. 31, 2008, on January 28, 2009. WellPoint, Inc. is currently in a quiet period prior to this scheduled earnings release, and therefore management will not be discussing earnings projections at the conference.

All interested parties are invited to listen to a webcast of the presentation by visiting www.wellpoint.com and selecting the "Investor Info" link. Following the presentation, a webcast replay will be available at www.wellpoint.com for two weeks.

To listen to the live webcast, please visit WellPoint's website at least 15 minutes early to download and install any necessary audio software. Individuals who listen to the presentation will be presumed to have read WellPoint's most recent filings with the SEC, including but not limited to its Annual Report on Form 10-K for the year ended Dec. 31, 2007, and its Quarterly Reports on Form 10-Q for the reporting periods of 2008.

About WellPoint, Inc.

WellPoint is committed to improving the lives and health of the people and communities we serve by simplifying the connection between health, care and value. Our goal is to help shape the impact each health care decision has on individuals, the health care system at-large, and our communities. WellPoint's more than 42,000 associates work every day to help create the best health care value for our customers. Through collaborations with providers and with innovative programs, WellPoint's affiliated health plans reward healthy lifestyles and quality, safe and effective care. As the nation's largest health benefits company, with more than 35 million members in its affiliated health plans, WellPoint is at the center of the health care system. This position provides us with the relationships and insights needed to help create affordable and actionable solutions that improve health care.

As an independent licensee of the Blue Cross and Blue Shield Association, WellPoint serves members as the Blue Cross licensee for California; the Blue Cross and Blue Shield licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri (excluding 30 counties in the Kansas City area), Nevada, New Hampshire, New York (as the Blue Cross Blue Shield licensee in 10 New York City metropolitan and surrounding counties and as the Blue Cross or Blue Cross Blue Shield licensee in selected upstate counties only), Ohio, Virginia (excluding the Northern Virginia suburbs of Washington, D.C.), Wisconsin; and through UniCare.

Health. Care. Value. Additional information about WellPoint is available at www.wellpoint.com.


'/>"/>
SOURCE WellPoint, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. WellPoint Announces Innovative Program to Help Improve the Care of Members Suffering With Bipolar Disorder
2. Healthbase Collaborates with WellPoint to Bring Affordable Medical Tourism Solutions
3. WellPoint to Hold Conference Call and Webcast to Discuss Fourth Quarter Results on January 28, 2009
4. WellPoint Announces Collaborative Partnership to Expand Access to Health Care Provider Information
5. Access MediQuip and WellPoint Finalize First National Contract for Implantable Medical Devices
6. WellPoint Associates Pledge Record Amount to Community Organizations in 2009
7. WellPoint Announces Appointment of Andrew J. Lang as Senior Vice President of Application Development
8. Dr. Charles Kennedy, Vice President of Health Information Technology for WellPoint, Inc., to Present Today at The 4th Annual World Healthcare Innovation and Technology Congress (WHIT v.4.0)
9. WellPoint Announces Second Annual Innovation Event
10. WellPoint Congratulates President-Elect Barack Obama
11. WellPoint Awarded Prestigious International Marketing Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... Halfway through its partnership with ... preventative dental services to more than 15,900 children 5 years old and younger and ... $38 million over a span of five years to Western University of Health Sciences, ...
(Date:12/2/2016)... Dothan, AL (PRWEB) , ... December 02, 2016 ... ... leaders from across the Dothan-Wiregrass Area in Alabama are expected to attend the ... Mike Schmitz, will help provide scholarship funds for area students and operating support ...
(Date:12/2/2016)... York, NY (PRWEB) , ... December 02, 2016 , ... ... an exclusive interview with Mediaplanet, Dr. Murthy explains how he was inspired to practice ... on I learned that medicine is about more than making diagnoses and prescribing medicine,” ...
(Date:12/2/2016)... ... ... Mediaplanet is proud to announce the launch of its ... therapeutic technologies, and revolutionized nutrition that are helping patients and physicians manage their ... the last 3 decades,” says Dr. Valentine Fuster, a world-renowned cardiologist. “This is ...
(Date:12/2/2016)... ... December 02, 2016 , ... Rijuven Corp launches rejiva ( http://www.rejiva.com ), a ... No other wearable health technology on the market can deliver all that rejiva can. ... meaningful insights about their health than the usual heart rate and steps taken”, adds ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)... 2016   Pairnomix, LLC, a genetic research company ... by the White House, today announced that findings from its ... of candidate therapies for a patient with epileptic encephalopathy caused ... presented at the 70 th Annual Meeting of the ... , December 2-6, 2016.  Pairnomix, unique process ...
(Date:12/4/2016)... , Dec. 3, 2016  Results from the Phase ... an anti-P-selectin antibody, reduced the median annual rate of ... placebo (1.63 vs 2.98, p=0.010) in patients with or ... the data are being featured in the official press ... Hematology (ASH) Annual Meeting and presented during the Plenary ...
(Date:12/4/2016)... Dec. 3, 2016  Findings from a Novartis ... CTL019, an investigational chimeric antigen receptor T cell ... young adult patients with B-cell acute lymphoblastic leukemia ... session at the 58th American Society of Hematology ... p.m.). The global Phase II study found that ...
Breaking Medicine Technology: